Larimar Therapeutics (LRMR) Financials

Larimar Therapeutics, Inc. (LRMR) is a biopharmaceutical company focused on developing innovative treatments for various genetic diseases. The company's financials demonstrate its commitment to advancing these therapies and creating value for its stockholders. The income statement provides a comprehensive view of Larimar's financial performance. It shows the company's revenue, expenses, and net income from stockholders. Larimar's total revenue reflects the sales generated from its therapeutic products and services. The gross profit represents the difference between the total revenue and the cost of goods sold. Larimar's net income from stockholders is the final profit that remains after deducting all expenses.

The balance sheet shows Larimar's financial position at a specific point in time. It provides information about the company's assets, liabilities, and stockholders' equity. Larimar's total assets include its cash equivalents, property, equipment, and other tangible and intangible assets. The total liabilities represent the company's obligations, such as debts and other financial obligations. Stockholders' equity reflects the ownership interest of investors in the company. Larimar's net debt is the difference between its total debt and cash equivalents. This metric measures the company's financial leverage and its ability to meet its short-term obligations.

Larimar's cash flow statement provides insights into the company's cash inflows and outflows. It includes the operating cash flow, investing cash flow, and financing cash flow. The operating cash flow measures the cash generated or used in the company's core operations. It reflects the cash from sales, payment of expenses, and other operating activities. The investing cash flow shows the cash used for acquiring or disposing of assets, such as property, equipment, and investments. The financing cash flow represents the cash flow from stock issuance, debt issuance, or debt repayment. Finally, Larimar's free cash flow is the cash left after deducting capital expenditures from the operating cash flow. This metric represents the amount of cash available for investments, debt repayment, or dividend payment.

In summary, Larimar Therapeutics, Inc. (LRMR) prioritizes its financial performance to advance the development of its innovative treatments. The company's income statement, balance sheet, and cash flow statement provide a comprehensive view of its financial status and demonstrate its dedication to creating value for its stockholders.